Literature DB >> 2041957

Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans.

R E Hawkins1, R A Moriarty, D E Lewis, E C Oldfield.   

Abstract

Chryseomonas luteola and Flavimonas oryzihabitans are phenotypically similar gram-negative bacilli and are also referred to as CDC groups Ve-1 and Ve-2, respectively. These bacteria are rarely reported as pathogens in humans. Infections described in the literature include primarily bacteremia in critically ill patients and peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. We describe three cases of polymicrobial infection secondary to infection with group Ve organisms, including the first reported case (to our knowledge) of CNS infection due to F. oryzihabitans. These three cases and a review of literature suggest an association between the presence of indwelling catheters and polymicrobial infections with CDC group Ve organisms. F. oryzihabitans and C. luteola should be added to the expanding list of nosocomial pathogens with a propensity to infect critically ill patients who have undergone surgical procedures and/or had indwelling catheters placed. The isolation of either of these organisms from clinical specimens should prompt a search for a device-related source.

Entities:  

Mesh:

Year:  1991        PMID: 2041957     DOI: 10.1093/clinids/13.2.257

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  13 in total

1.  A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  Stamatina Papakonstantinou; Evangelia Dounousi; Kyriakos Ioannou; Ioannis Tsouchnikas; Apostolos Kelesidis; Nikolaos Kotzadamis; Dimitrios Tsakiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

Authors:  A Giacometti; O Cirioni; M Quarta; A M Schimizzi; M S Del Prete; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

3.  Orthopaedic referrals from a cardiothoracic transplant population.

Authors:  D S Johnson; T H Meadows
Journal:  Ann R Coll Surg Engl       Date:  1997-03       Impact factor: 1.891

4.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

5.  Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.

Authors:  A Kansouzidou; C Charitidou; E Poubrou; V D Daniilidis; H Tsagaropoulou
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

6.  Infection of hickman catheter by Pseudomonas (formerly flavimonas) oryzihabitans traced to a synthetic bath sponge.

Authors:  M Marín; D García de Viedma; P Martín-Rabadán; M Rodríguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 7.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

8.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

9.  Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital.

Authors:  Wafae Chihab; Ahmed S Alaoui; Mohamed Amar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.